KB407’s positive set of results presented at ATS 2026 follows a set of similar positive results that were announced for the ...
The results provide validation of the DPP1 inhibition in bronchiectasis and reinforce the drug class’s position in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results